Evaluation status available after sign-in
About the journal
JCI Insight is an open-access journal published by American Society for Clinical investigation in United States, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 5,000 USD. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- American Society for Clinical investigation
- ISSN
- 2379-3708
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 5,000 USD
- Articles in DOAJ
- 3314
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://insight.jci.org/
Index listings
- DOAJ · 2020-10-29
- MEDLINE · 2017-01-01
- PUBMED · 2016-01-21
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 5,000 USD
- Declared review time (DOAJ)
- 6 weeks
- Actual review time (measured)
- 274 days received→accepted — computed from PubMed (n=52)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
3314
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
5311
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
172
i10-index
3892
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-09-14
- Added to DOAJ
- 2020-10-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMC
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 95%
- ORCID iDs in current deposits
- 79%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JCI Insight
- Source type
- journal
- NLM unique ID (PubMed)
- 101676073
Classification2
Subjects (DOAJ)
Medicine
LCC codes
R
Subject areas
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Cancer Immunotherapy and Biomarkers
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
Show all subjects (75)
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune cells in cancer
- SARS-CoV-2 and COVID-19 Research
- Pancreatic function and diabetes
- Pancreatic function and diabetes
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- HIV Research and Treatment
- Transplantation: Methods and Outcomes
- COVID-19 Clinical Research Studies
- CAR-T cell therapy research
- CAR-T cell therapy research
- SARS-CoV-2 and COVID-19 Research
- Chronic Kidney Disease and Diabetes
- SARS-CoV-2 and COVID-19 Research
- Neonatal Respiratory Health Research
- Neonatal Respiratory Health Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Immune Response and Inflammation
- Immune cells in cancer
- Immune Response and Inflammation
- Adipose Tissue and Metabolism
- Adipose Tissue and Metabolism
- Pancreatic function and diabetes
- Muscle Physiology and Disorders
- Epigenetics and DNA Methylation
- Cardiac Fibrosis and Remodeling
- HIV Research and Treatment
- Epigenetics and DNA Methylation
- HIV Research and Treatment
- Asthma and respiratory diseases
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Systemic Lupus Erythematosus Research
- Cardiac electrophysiology and arrhythmias
- Adipokines, Inflammation, and Metabolic Diseases
- Acute Kidney Injury Research
- Immune responses and vaccinations
- Diabetes and associated disorders
- Hematopoietic Stem Cell Transplantation
- Psoriasis: Treatment and Pathogenesis
- Liver physiology and pathology
- Diabetes and associated disorders
- Diabetes and associated disorders
- Renal Diseases and Glomerulopathies
- Virus-based gene therapy research
- IL-33, ST2, and ILC Pathways
- RNA modifications and cancer
- Liver Disease Diagnosis and Treatment
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- RNA modifications and cancer
- Mitochondrial Function and Pathology
- Liver Disease Diagnosis and Treatment
- IL-33, ST2, and ILC Pathways
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Mitochondrial Function and Pathology
- Muscle Physiology and Disorders
- Muscle Physiology and Disorders
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Asthma and respiratory diseases
- Cancer, Hypoxia, and Metabolism
- Asthma and respiratory diseases
- Cancer, Hypoxia, and Metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
Keywords (DOAJ)
- biomedicine
- biology
- precision medicine
- immunology
- genetics
- autoimmunity
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ